
# Title 26 - Internal Revenue
## Chapter I - Internal Revenue Service, Department of the Treasury
### Subchapter A - Income Tax
#### PART 1 - INCOME TAXES
##### Changes in Rates During a Taxable Year
###### ยง 1.28-1 Credit for clinical testing expenses for certain drugs for rare diseases or conditions.
####### Definition of "human clinical testing."

(2)Testing is considered to be human clinical testing only to the extent that it uses human subjects to determine the effect of the designated drug on humans and is necessary for the designated drug either to be approved under section 505(b) of the Federal Food, Drug, and Cosmetic Act and the regulations thereunder (21 CFR part 314), or if the designated drug is a biological product (other than a radioactive biological product intended for human use), to be licensed under section 351 of the Public Health Services Act and the regulations thereunder (21 CFR part 601). For purposes of this paragraph (c)(2), a human subject is an individual who is a participant in research, either as a recipient of the drug or as a control. A subject may be either a healthy individual or a patient.
